leisure time -WSS

leisure time

author：entertainment 2025-09-29 20:50:47 - browse：3755

Powdered ibogaine against a white background. — Tabernanthe iboga, the shrub that contains the psychedelic substance ibogaine. Wikimedia Commons

The psychedelic ibogaine is unlikely to ever receive approval as a treatment for opioid addiction, the federal government’s top addiction researcher said Thursday.

The remarks from Nora Volkow, the longtime director of the National Institute on Drug Abuse, serve as a cautionary note amid widespread enthusiasm about ibogaine, a naturally occurring substance that drug companies and researchers have increasingly cast as a potential paradigm-shifting addiction treatment.

But its potential cardiac side effects could stand in the way of receiving approval from the Food and Drug Administration, Volkow said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Synthetic human embryos? Researchers say term is overblown

WSS

Biden's order seeks to regulate AI risk without stifling innovation

Testing for cancer recurrence creates a new limbo for patients

Medical experts exlpore how to eliminate bias in clinical algorithms

Tuskegee Airman Raymond Cassagnol dies at 102

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

First Opinion Podcast: How to protect health care in times of war

entertainment

leisure time

focus

BioMarin wins approval for gene therapy to treat hemophilia A

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Medical leaders decry Supreme Court decision on affirmative action

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

UnitedHealth wins $3.3 billion takeover of Amedisys

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Telehealth options flood the market as retailers push virtual care

State Dept. review finds Biden bears some blame for Afghanistan failures

GOP inquiry over gain

entertainment

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Illumina to lay off 10% of research and development team

FDA has safety concerns on CRISPR

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

WHO may add ‘noma' to its list of neglected tropical diseases

focus

entertainment

explore

leisure time